Correlation Between Alterola Biotech and Antisense Therapeutics

Can any of the company-specific risk be diversified away by investing in both Alterola Biotech and Antisense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alterola Biotech and Antisense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alterola Biotech and Antisense Therapeutics Limited, you can compare the effects of market volatilities on Alterola Biotech and Antisense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alterola Biotech with a short position of Antisense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alterola Biotech and Antisense Therapeutics.

Diversification Opportunities for Alterola Biotech and Antisense Therapeutics

-0.25

Correlation Coefficient

Alterola Biotech  Antisense Therapeutics

Very good diversification

The 3 months correlation between Alterola and Antisense is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Alterola Biotech and Antisense Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antisense Therapeutics and Alterola Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alterola Biotech are associated (or correlated) with Antisense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antisense Therapeutics has no effect on the direction of Alterola Biotech i.e., Alterola Biotech and Antisense Therapeutics go up and down completely randomly.

Pair Corralation between Alterola Biotech and Antisense Therapeutics

Given the investment horizon of 90 days Alterola Biotech is expected to generate 2.27 times less return on investment than Antisense Therapeutics. But when comparing it to its historical volatility, Alterola Biotech is 1.88 times less risky than Antisense Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Antisense Therapeutics Limited is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1.20  in Antisense Therapeutics Limited on September 13, 2024 and sell it today you would earn a total of  3.00  from holding Antisense Therapeutics Limited or generate 250.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Alterola Biotech  vs.  Antisense Therapeutics Limited

Alterola Biotech

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Alterola Biotech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Alterola Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Antisense Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Antisense Therapeutics Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward-looking indicators, Antisense Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Alterola Biotech and Antisense Therapeutics

The main advantage of trading using opposite Alterola Biotech and Antisense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alterola Biotech position performs unexpectedly, Antisense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antisense Therapeutics will offset losses from the drop in Antisense Therapeutics' long position.

The idea behind Alterola Biotech and Antisense Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.